secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ingevity Corp (NGVT)
CIK:        0001653477
Form:       8-K
Filed at:   2025-02-18T23:59:59+00:00
Accession:  0001653477-25-000011
Event type: earnings
Sentiment:  neutral
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ingevity Q4 net sales down 20% YoY to $298.8M; full-year net loss $430.3M
-------------------------------------------------------------------------

- Q4 net sales $298.8M (-20% YoY); adjusted EBITDA $80.6M (margin 27.0%); net income $16.6M includes $23.4M restructuring charges.
- Full-year net sales $1.4B (-17% YoY); net loss $430.3M on $688M pre-tax charges in Performance Chemicals; adjusted EPS $3.51.
- 2025 guidance: sales $1.3B-$1.4B, adjusted EBITDA $400M-$415M, free cash flow $220M-$260M.
- In January 2025, began exploring strategic alternatives for Performance Chemicals Industrial Specialties line and North Charleston CTO refinery.
- Q4 operating cash flow $64.5M included final $50M termination fee payment from a long-term CTO supply agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1653477/000165347725000011/0001653477-25-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1653477/000165347725000011/ngvt-20250218.htm
  HTML page:      https://secwatch.observer/filing/0001653477-25-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer